Pathways Neuro Pharma, Inc.
Home
Programs
  • Pipeline
  • PINK1 Gene Therapy
  • DRD1A Receptor Therapy
  • Early-Onset Parkinson's
Science
  • Gene Therapy
  • Pharmaceutical Discovery
About
Contact
NEWS
  • Press Releases & Podcasts
  • Papers & Presentations
Pathways Neuro Pharma, Inc.
Home
Programs
  • Pipeline
  • PINK1 Gene Therapy
  • DRD1A Receptor Therapy
  • Early-Onset Parkinson's
Science
  • Gene Therapy
  • Pharmaceutical Discovery
About
Contact
NEWS
  • Press Releases & Podcasts
  • Papers & Presentations
More
  • Home
  • Programs
    • Pipeline
    • PINK1 Gene Therapy
    • DRD1A Receptor Therapy
    • Early-Onset Parkinson's
  • Science
    • Gene Therapy
    • Pharmaceutical Discovery
  • About
  • Contact
  • NEWS
    • Press Releases & Podcasts
    • Papers & Presentations
  • Home
  • Programs
    • Pipeline
    • PINK1 Gene Therapy
    • DRD1A Receptor Therapy
    • Early-Onset Parkinson's
  • Science
    • Gene Therapy
    • Pharmaceutical Discovery
  • About
  • Contact
  • NEWS
    • Press Releases & Podcasts
    • Papers & Presentations

Contact Us

Anthony Mack

President and CEO 

anthony.mack@pathwaysnp.com 



Pathways Neuro Pharma, Inc.

1055 Westlakes Drive suite 300, Berwyn, PA 19312, USA

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Connect With Us

 All Pathways programs are investigational. Safety and efficacy have not been established in humans. Nothing on this website constitutes an offer to sell or a solicitation to buy any security. Pathways Neuro Pharma, Inc. — 1055 Westlakes Drive, Suite 300, Berwyn, PA 19312 · 

© 2026 Pathways Neuro Pharma, Inc. 

All rights reserved 

  • Home
  • Pipeline
  • PINK1 Gene Therapy
  • Early-Onset Parkinson's
  • Gene Therapy
  • Pharmaceutical Discovery
  • Contact
  • Press Releases & Podcasts
  • Papers & Presentations